PharmaShots | Incisive News in 3 Shots

Subscribe Now

nAMD

Coherus Report Results of CHS-201 (biosimilar- ranibizumab) in COLUMBUS-AMD Clinical Trial for the Treatment of nAMD

Coherus Report Results of CHS-201 (biosimilar- ranibizumab) in COLUMBUS-AMD Clinical Trial for the Treatment of nAMD

October 5, 2021

Samsung Bioepis Reports Results of Post-Hoc Analysis from P-III Study of Byooviz (biosimilar- ranibizumab) for the Treatment of nAMD

Samsung Bioepis Reports Results of Post-Hoc Analysis from P-III Study of Byooviz (biosimilar- ranibizumab) for the Treatment of nA...

September 10, 2021

Allergan and Molecular Partners Report Result of Abicipar pegol in P-III MAPLE Study for Neovascular Macular Degeneration (nAMD)

Allergan and Molecular Partners Report Result of Abicipar pegol in P-III MAPLE Study for Neovascular Macular Degeneration (nAMD)

April 3, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us